Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1677 to 1726 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1677\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribonuclease hi large subunit (ec 3.1.26.-) (rnase hi large subunit) (rnase h(35)) (ribonuclease h2) (rnase h2). [source:swissprot;acc:o75792]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6075.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6496.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06937\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1678\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage and polyadenylation specific factor 5, 25 kd subunit; pre-mrna cleavage factor im (25kd); pre-mrna cleavage factor im, 25kd subunit. [source:refseq;acc:nm\_007006]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5763.25\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6162.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06936\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1679\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit beta type 3 (ec 3.4.25.1) (proteasome theta chain) (proteasome chain 13) (proteasome component c10-ii). [source:swissprot;acc:p49720]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6180.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6608.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06923\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1680\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
methylenetetrahydrofolate reductase (ec 1.5.1.20). [source:swissprot;acc:p42898]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6436.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6882.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0692\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1681\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
f-actin capping protein alpha-3 subunit (capz alpha-3) (germ cell- specific protein 3). [source:swissprot;acc:q96kx2]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6304.74\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6740.66\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06914\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1682\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
f-actin capping protein beta subunit (capz beta). [source:swissprot;acc:p47756]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1683\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ring finger protein 20. [source:refseq;acc:nm\_019592]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5419.54\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5793.94\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06908\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1684\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ring finger protein 40; 95 kda retinoblastoma protein binding protein; likely ortholog of rat staring. [source:refseq;acc:nm\_014771]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1685\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gc-rich sequence dna-binding factor homolog. [source:swissprot;acc:q9y5b6]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6088.07\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6508.45\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06905\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1686\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
toll-like receptor 2 precursor (toll/interleukin 1 receptor-like protein 4). [source:swissprot;acc:o60603]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1687\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serpin b12. [source:swissprot;acc:q96p63]\vspace{3pt}}&\multirow{9}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5767.69\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6165.87\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06904\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1688\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
megsin (tp55) (serpin b7). [source:swissprot;acc:o75635]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1689\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hurpin (hacat uv-repressible serpin) (protease inhibitor 13) (headpin) (serpin b13). [source:swissprot;acc:q9uiv8]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1690\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
oxysterols receptor lxr-beta (liver x receptor beta) (nuclear orphan receptor lxr-beta) (ubiquitously-expressed nuclear receptor) (nuclear receptor ner). [source:swissprot;acc:p55055]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1691\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
upf0183 protein. [source:swissprot;acc:q9bsu1]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1692\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
antithrombin-iii precursor (atiii) (pro0309). [source:swissprot;acc:p01008]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1693\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
translation initiation factor eif-2b alpha subunit (eif-2b gdp-gtp exchange factor). [source:swissprot;acc:q14232]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1694\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
squamous cell carcinoma antigen 1 (scca-1) (protein t4-a). [source:swissprot;acc:p29508]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1695\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
oxysterols receptor lxr-alpha (liver x receptor alpha) (nuclear orphan receptor lxr-alpha). [source:swissprot;acc:q13133]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1696\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
wiskott-aldrich syndrome protein family member 2 (wasp-family protein member 2) (verprolin homology domain-containing protein 2). [source:swissprot;acc:q9y6w5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6304.22\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6738.77\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06893\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1697\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
wiskott-aldrich syndrome protein family member 3 (wasp-family protein member 3) (verprolin homology domain-containing protein 3). [source:swissprot;acc:q9upy6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6304.21\vspace{3pt}}&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1698\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
wiskott-aldrich syndrome protein family member 1 (wasp-family protein member 1) (verprolin homology domain-containing protein 1). [source:swissprot;acc:q92558]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6304.22\vspace{3pt}}&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1699\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rest corepressor. [source:refseq;acc:nm\_015156]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6304.21\vspace{3pt}}&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1700\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidylinositol-4-phosphate 3-kinase c2 domain-containing gamma polypeptide (ec 2.7.1.154) (phosphoinositide 3-kinase-c2-gamma) (ptdins-3-kinase c2 gamma) (pi3k-c2gamma). [source:swissprot;acc:o75747]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6326.24\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6762.27\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06892\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1701\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidylinositol-4-phosphate 3-kinase c2 domain-containing beta polypeptide (ec 2.7.1.154) (phosphoinositide 3-kinase-c2-beta) (ptdins-3-kinase c2 beta) (pi3k-c2beta) (c2-pi3k). [source:swissprot;acc:o00750]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1702\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dynamin 1-like protein isoform 3; dynamin-like protein. [source:refseq;acc:nm\_005690]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1703\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphoinositide-3-kinase, class 2, alpha polypeptide; c2-containing phosphatidylinositol kinase. [source:refseq;acc:nm\_002645]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1704\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein six1 (sine oculis homeobox homolog 1). [source:swissprot;acc:q15475]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5778.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6176.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06883\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1705\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
translation initiation factor eif-2b epsilon subunit (eif-2b gdp-gtp exchange factor). [source:swissprot;acc:q13144]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5369.43\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5738.73\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06878\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1706\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
translation initiation factor eif-2b gamma subunit (eif-2b gdp-gtp exchange factor). [source:swissprot;acc:q9nr50]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1707\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proliferation-associated protein 2g4 (cell cycle protein p38-2g4 homolog) (hg4-1). [source:swissprot;acc:q9uq80]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5777.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6174.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06873\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1708\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
metaxin 2. [source:swissprot;acc:o75431]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7033.72\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7516.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06868\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1709\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein six2 (sine oculis homeobox homolog 2). [source:swissprot;acc:q9npc8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5775.55\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6171.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06861\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1710\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
camp-dependent protein kinase type ii-alpha regulatory chain. [source:swissprot;acc:p13861]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5916.13\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6321.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06857\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1711\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase pkx1 (ec 2.7.1.-). [source:swissprot;acc:p51817]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5917.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6322.72\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06853\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1712\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
camp-dependent protein kinase, gamma-catalytic subunit (ec 2.7.1.37) (pka c-gamma). [source:swissprot;acc:p22612]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5917.23\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6322.73\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1713\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
camp-dependent protein kinase, beta-catalytic subunit (ec 2.7.1.37) (pka c-beta). [source:swissprot;acc:p22694]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1714\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
camp-dependent protein kinase, alpha-catalytic subunit (ec 2.7.1.37) (pka c-alpha). [source:swissprot;acc:p17612]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1715\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
camp-dependent protein kinase type ii-beta regulatory chain. [source:swissprot;acc:p31323]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5918.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6323.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06849\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1716\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
inositol-1(or 4)-monophosphatase 2 (ec 3.1.3.25) (impase 2) (imp 2) (inositol monophosphatase 2) (myo-inositol monophosphatase a2). [source:swissprot;acc:o14732]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6070.41\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6485.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06844\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1717\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
inositol-1(or 4)-monophosphatase (ec 3.1.3.25) (impase) (imp) (inositol monophosphatase) (lithium-sensitive myo-inositol monophosphatase a1). [source:swissprot;acc:p29218]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6069.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6484.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06842\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1718\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
coatomer alpha subunit (alpha-coat protein) (alpha-cop) (hepcop) (hep-cop) [contains: xenin (xenopsin-related peptide); proxenin]. [source:swissprot;acc:p53621]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9720.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9099.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06831\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1719\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mannose-6-phosphate isomerase (ec 5.3.1.8) (phosphomannose isomerase) (pmi) (phosphohexomutase). [source:swissprot;acc:p34949]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5458.12\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5830.76\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06827\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1720\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative ankyrin-repeat containing protein. [source:refseq;acc:nm\_025185]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1721\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mln 64 protein (star-related lipid transfer protein 3) (stard3) (start domain-containing protein 3) (cab1 protein). [source:swissprot;acc:q14849]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1722\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protocadherin fat 2 precursor (hfat2) (multiple epidermal growth factor-like domains 1). [source:swissprot;acc:q9nyq8]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1723\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cadherin-related tumor suppressor homolog precursor (fat protein homolog). [source:swissprot;acc:q14517]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1724\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mln64 n-terminal domain homolog (stard3 n-terminal like protein). [source:swissprot;acc:o95772]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1725\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glucose-6-phosphate isomerase (ec 5.3.1.9) (gpi) (phosphoglucose isomerase) (pgi) (phosphohexose isomerase) (phi) (neuroleukin) (nlk) (sperm antigen-36) (sa-36). [source:swissprot;acc:p06744]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6051.06\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6463.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06818\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1726\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal 3,2-trans-enoyl-coa isomerase (ec 5.3.3.8) (dodecenoyl-coa delta-isomerase) (d3,d2-enoyl-coa isomerase) (dbi-related protein 1) (drs-1) (hepatocellular carcinoma-associated antigen 88). [source:swissprot;acc:o75521]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7048.79\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7527.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0679\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/